Oak Street Health, Inc. (OSH) — Financial statements
Income statement, balance sheet, and cash flow for Oak Street Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2,161↑50.8% | 1,433↑62.3% | 883↑58.6% | 557↑75.1% | 318 | |
| Cost of Revenue | 2,083↑48.5% | 1,403↑74.2% | 805↑52.9% | 527↑68.0% | 314 | |
| Gross Profit | 78↑161.2% | 30↓61.4% | 77↑160.2% | 30↑574.1% | 4 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 345↑12.4% | 307↑65.3% | 185↑133.1% | 80↑56.7% | 51 | |
| Selling & Marketing Expenses | 164↑37.6% | 119↑85.9% | 64↑39.0% | 46↑81.3% | 25 | |
| SG&A Expenses | 509↑19.5% | 426↑70.6% | 250↑98.5% | 126↑64.9% | 76 | |
| Other Expenses | 35↑97.8% | 18↑58.6% | 11↑43.0% | 8↑87.7% | 4 | |
| Operating Expenses | 544↑22.6% | 444↑70.1% | 261↑95.3% | 134↑66.1% | 80 | |
| Total Costs & Expenses | 2,627↑42.3% | 1,847↑73.2% | 1,066↑61.4% | 660↑67.6% | 394 | |
| Operating Results | ||||||
| Operating Income | -466↓12.6% | -414↓125.6% | -184↓76.7% | -104↓36.6% | -76 | |
| Depreciation & Amortization | -6↓131.5% | 18↑56.4% | 11↑43.5% | 8↑89.7% | 4 | |
| EBITDA | -472↓19.1% | -396↓130.2% | -172↓79.4% | -96↓33.9% | -72 | |
| EBIT | -507↓22.5% | -414↓125.8% | -183↓76.7% | -104↓36.5% | -76 | |
| Interest & Other Income | ||||||
| Net Interest Income | -3↑0.0% | -3↑71.3% | -9↓54.2% | -6↓53.2% | -4 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 3↑0.0% | 3↓71.3% | 9↑54.2% | 6↑53.2% | 4 | |
| Non-Operating Income | 41 | 0.00↑100.0% | -0.16↓85.7% | -0.08↓740.0% | -0.01 | |
| Other Income / Expenses | -43↓1632.0% | -3↑70.8% | -9↓53.7% | -6↓51.4% | -4 | |
| Income Before Tax | -510↓22.3% | -417↓116.8% | -192↓75.5% | -109↓37.3% | -80 | |
| Income Tax Expense | 0.20↑110.5% | -2↓139.7% | 5↑15.1% | 4↑41440.0% | 0.01 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -510↓22.9% | -415↓110.6% | -197↓73.3% | -114↓42.8% | -80 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -510↓22.9% | -415↓110.6% | -197↓73.3% | -114↓42.8% | -80 | |
| Bottom-Line Net Income | -510↓22.9% | -415↓110.6% | -197↓73.3% | -114↓42.8% | -80 | |
| EPS (Basic) | -2.21↓18.8% | -1.86↓106.7% | -0.90↓60.7% | -0.56↓43.6% | -0.39 | |
| EPS (Diluted) | -2.21↓18.8% | -1.86↓106.7% | -0.90↓60.7% | -0.56↓43.6% | -0.39 | |
| Weighted Average Shares | 230↑3.4% | 223↑1.7% | 219↑7.2% | 204↑0.0% | 204 | |
| Weighted Average Diluted Shares | 230↑3.4% | 223↑1.7% | 219↑7.2% | 204↑0.0% | 204 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.